{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:26:26Z","timestamp":1790519186301,"version":"4.1.0"},"reference-count":225,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"EULAR Study Group on Microcirculation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.autrev.2017.05.024","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T00:00:35Z","timestamp":1496188835000},"page":"774-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review"],"prefix":"10.1016","volume":"16","author":[{"given":"Y.","family":"Mostmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giddelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Decuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Melsens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vandecasteele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0010","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0015","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0020","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","article-title":"Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis","volume":"15","author":"Cabral-Marques","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2017.05.024_bb0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0190-9622(92)70165-C","article-title":"Expression of adhesion proteins involved in cell-cell and cell-matrix interactions in the skin of patients with progressive systemic sclerosis","volume":"27","author":"Gruschwitz","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.1780380206","article-title":"Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity","volume":"38","author":"Gruschwitz","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0050","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/rheumatology\/37.11.1188","article-title":"Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis","volume":"37","author":"Ihn","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0055","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/1529-0131(200005)43:5<1085::AID-ANR19>3.0.CO;2-7","article-title":"Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1","volume":"43","author":"Andersen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0065","first-page":"2565","article-title":"Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation","volume":"29","author":"Macko","year":"2002","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/03009742.2013.796403","article-title":"Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis","volume":"42","author":"Iversen","year":"2013","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/09537100701882038","article-title":"Significance of microparticles in progressive systemic sclerosis with interstitial pneumonia","volume":"19","author":"Nomura","year":"2008","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.1780350307","article-title":"Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset","volume":"35","author":"Sollberg","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00408-015-9718-6","article-title":"In situ evidence of pulmonary endothelial activation in patients with granulomatosis with polyangiitis and systemic sclerosis","volume":"193","author":"Kawano-Dourado","year":"2015","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.024_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mvr.2016.07.002","article-title":"Capillaroscopic findings and vascular biomarkers in systemic sclerosis: association of low CD40L levels with late scleroderma pattern","volume":"108","author":"Yal\u00e7\u0131nkaya","year":"2016","journal-title":"Microvasc Res"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/art.1780400321","article-title":"Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage","volume":"40","author":"Gruschwitz","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/clin.1993.1100","article-title":"Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis","volume":"68","author":"Sfikakis","year":"1993","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/37.3.304","article-title":"Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin","volume":"37","author":"S\u00f8ndergaard","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0115","first-page":"483","article-title":"Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis","volume":"12","author":"Kiener","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0120","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/rheumatology\/36.12.1270","article-title":"Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines","volume":"36","author":"Ihn","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/art.37712","article-title":"Differential expression of junctional adhesion molecules in different stages of systemic sclerosis","volume":"65","author":"Manetti","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/ard.2008.102624","article-title":"Junctional adhesion molecule-a is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion","volume":"69","author":"Hou","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kep091","article-title":"The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1","volume":"48","author":"Rabquer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Suppl. 65","key":"10.1016\/j.autrev.2017.05.024_bb0140","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2017.05.024_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10875-014-0037-0","article-title":"Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels","volume":"34","author":"Vettori","year":"2014","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0155","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0160","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/art.22010","article-title":"Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta","volume":"54","author":"Del Galdo","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0165","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ard.2003.018705","article-title":"Up regulated expression of fractalkine\/CX3CL1 and CX3CR1 in patients with systemic sclerosis","volume":"64","author":"Hasegawa","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0175","first-page":"527","article-title":"Increased serum fractalkine in systemic sclerosis. Down-regulation by prostaglandin E1","volume":"26","author":"Sicinska","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0180","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000093846","article-title":"A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease","volume":"213","author":"Fujimoto","year":"2006","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0190","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets\u2014a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0195","first-page":"1325","article-title":"Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon","volume":"20","author":"Blann","year":"1993","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0205","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome","volume":"36","author":"Ames","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.1993.tb03145.x","article-title":"Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis","volume":"84","author":"Goodfield","year":"1993","journal-title":"Br J Haematol"},{"issue":"4 pt 1","key":"10.1016\/j.autrev.2017.05.024_bb0215","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon","volume":"94","author":"Kahaleh","year":"1981","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0220","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1182\/blood.V73.6.1586.1586","article-title":"Supranormal von Willebrand factor multimers in scleroderma","volume":"73","author":"Mannucci","year":"1989","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0225","first-page":"359","article-title":"Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis","volume":"78","author":"Holt","year":"1989","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0230","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0235","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI2261","article-title":"The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis","volume":"101","author":"Bordron","year":"1998","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0240","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/art.21952","article-title":"Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0245","first-page":"468","article-title":"Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis","volume":"15","author":"Drenk","year":"1988","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/jaut.1999.0355","article-title":"Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (scleroderma)","volume":"14","author":"Nguyen","year":"2000","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0255","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02274825","article-title":"IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders","volume":"10","author":"Quadros","year":"1990","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0260","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0265","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.1780311209","article-title":"The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity","volume":"31","author":"Marks","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0270","first-page":"548","article-title":"Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis","volume":"57","author":"Penning","year":"1984","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0275","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3899\/jrheum.091346","article-title":"Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis","volume":"37","author":"Del Papa","year":"2010","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1172\/JCI118377","article-title":"IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines","volume":"97","author":"Carvalho","year":"1996","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0285","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0290","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00296-009-1068-3","article-title":"Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis","volume":"30","author":"Okazaki","year":"2010","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.0022-202X.2003.22121.x","article-title":"Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma","volume":"122","author":"Yamamoto","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0300","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/rheumatology\/keq372","article-title":"Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis","volume":"50","author":"Costa","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0305","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1002\/art.22266","article-title":"A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16","volume":"54","author":"Mondini","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0310","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jcmm.12105","article-title":"Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma","volume":"17","author":"Wang","year":"2013","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0315","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/art.20116","article-title":"Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis","volume":"50","author":"Del Papa","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0320","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/rheumatology\/keq064","article-title":"The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker?","volume":"49","author":"Castellino","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114856","article-title":"The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study","volume":"10","author":"Scambi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1752-699X.2008.00118.x","article-title":"Collagen V and vascular injury promote lung architectural changes in systemic sclerosis","volume":"3","author":"Parra","year":"2009","journal-title":"Clin Respir J"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0335","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.23735","article-title":"The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis","volume":"58","author":"Guiducci","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.024_bb0340","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12891-015-0653-8","article-title":"Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis","volume":"16","author":"Iversen","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"issue":"23","key":"10.1016\/j.autrev.2017.05.024_bb0345","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","article-title":"Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis","volume":"120","author":"Maurer","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0350","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2002","article-title":"A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients","volume":"8","author":"Giusti","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0355","first-page":"1529","article-title":"Elevated vascular endothelial growth factor in systemic sclerosis","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0360","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0365","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0375","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1155\/MI.2005.144","article-title":"Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients","volume":"2005","author":"Dziankowska-Bartkowiak","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2017.05.024_bb0380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.resp.2014.10.018","article-title":"Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma","volume":"209","author":"G\u0142odkowska-Mr\u00f3wka","year":"2015","journal-title":"Respir Physiol Neurobiol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0385","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3899\/jrheum.080516","article-title":"Abnormalities in the regulators of angiogenesis in patients with scleroderma","volume":"36","author":"Hummers","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0390","first-page":"641","article-title":"Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin","volume":"20","author":"Mackiewicz","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"9434","key":"10.1016\/j.autrev.2017.05.024_bb0395","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0400","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/rheumatology\/ker447","article-title":"Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis","volume":"51","author":"Carrai","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0405","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1756-185X.12130","article-title":"Dysregulation of angiogenic homeostasis in systemic sclerosis","volume":"16","author":"Farouk","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0410","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10067-016-3219-8","article-title":"Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis","volume":"35","author":"Silva","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0415","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0420","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/art.23968","article-title":"Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions","volume":"58","author":"Avouac","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0425","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1684\/ejd.2011.1284","article-title":"Expression pattern of VEGFR-1, \u22122, \u22123 and D2-40 protein in the skin of patients with systemic sclerosis","volume":"21","author":"Higashi-Kuwata","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0430","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-2133.2009.09567.x","article-title":"Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis","volume":"162","author":"Jinnin","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0435","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/030097401753180372","article-title":"Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis","volume":"30","author":"Silveri","year":"2001","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0440","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.38953","article-title":"Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis","volume":"67","author":"Shirai","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0445","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-012-1307-4","article-title":"Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis","volume":"305","author":"Noda","year":"2013","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0450","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1468-3083.2011.04012.x","article-title":"Serum Tie2 levels: clinical association with microangiopathies in patients with systemic sclerosis","volume":"25","author":"Noda","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0455","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/keq392","article-title":"Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease","volume":"50","author":"Michalska-Jakubus","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0460","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1684\/ejd.2012.1774","article-title":"Serum angiopoietin-like protein 3 concentrations in rheumatic diseases","volume":"22","author":"Hayashi","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0465","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jdermsci.2010.04.004","article-title":"Elevated serum placenta growth factor (PlGF) levels in patients with systemic sclerosis: a possible role in the development of skin but not lung fibrosis","volume":"58","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol Sci"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0470","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/annrheumdis-2011-200143","article-title":"Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis","volume":"71","author":"Avouac","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0475","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","article-title":"Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis","volume":"43","author":"Hebbar","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0480","first-page":"1524","article-title":"Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis","volume":"30","author":"Furuse","year":"2003","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0485","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2011-200837","article-title":"Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage","volume":"71","author":"Manetti","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0490","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0495","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/path.2048","article-title":"Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor","volume":"210","author":"Serrat\u00ec","year":"2006","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0500","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/art.27522","article-title":"Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12","volume":"62","author":"Margheri","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0505","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/art.22263","volume":"54","author":"Margheri","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0510","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1002\/art.21383","article-title":"The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis","volume":"52","author":"Giusti","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0515","first-page":"415","article-title":"Differential expression of tissue kallikrein in the skin of systemic sclerosis","volume":"20","author":"Milia","year":"2005","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032272","article-title":"A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis","volume":"7","author":"Noda","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0525","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0535","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0545","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0550","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3899\/jrheum.110755","article-title":"Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis","volume":"39","author":"Taniguchi","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-3083.2011.04354.x","article-title":"Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis","volume":"27","author":"Aozasa","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0560","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/exd.12602","article-title":"A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis","volume":"24","author":"Saigusa","year":"2015","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0565","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0570","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/rheumatology\/kem313","article-title":"CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis\u2014a longitudinal study","volume":"47","author":"Antonelli","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0580","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/art.22047","article-title":"Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications","volume":"54","author":"Cipriani","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0585","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3899\/jrheum.090108","article-title":"Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0590","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2133.2009.09507.x","article-title":"CCL13 is a promising diagnostic marker for systemic sclerosis","volume":"162","author":"Yanaba","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0595","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00403-010-1078-8","article-title":"Serum CCL23 levels are increased in patients with systemic sclerosis","volume":"303","author":"Yanaba","year":"2011","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0600","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0605","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1600-0560.2006.00584.x","article-title":"Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis","volume":"34","author":"Chaudhuri","year":"2007","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0610","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.00378.2006","article-title":"Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension","volume":"293","author":"Arciniegas","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0615","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0620","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2353\/ajpath.2009.090698","article-title":"Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy","volume":"175","author":"Kizu","year":"2009","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0625","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0630","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2353\/ajpath.2009.090096","article-title":"Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice","volume":"175","author":"Li","year":"2009","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0635","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-016-1122-y","article-title":"Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study","volume":"18","author":"Corallo","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0640","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/art.30317","article-title":"Protein kinase C\u03b4 and c-Abl kinase are required for transforming growth factor \u03b2 induction of endothelial-mesenchymal transition in vitro","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0645","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2012.10.022","article-title":"Caveolin-1 deficiency induces spontaneous endothelial-to-mesenchymal transition in murine pulmonary endothelial cells in vitro","volume":"182","author":"Li","year":"2013","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0650","doi-asserted-by":"crossref","first-page":"C550","DOI":"10.1152\/ajpcell.00123.2010","article-title":"Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis","volume":"300","author":"Xu","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0655","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jcp.24337","article-title":"Interferon-\u03b3 promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) \u03b22","volume":"228","author":"Chrobak","year":"2013","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0660","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell Gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161988","article-title":"Stimulation of transforming growth factor-\u03b21-induced endothelial-to-mesenchymal transition and tissue fibrosis by endothelin-1 (ET-1): a novel profibrotic effect of ET-1","volume":"11","author":"Wermuth","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0670","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0675","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2011-200713","article-title":"Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols","volume":"71","author":"Kuwana","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0680","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","article-title":"Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance","volume":"8","author":"Hristov","year":"2004","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0685","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0690","first-page":"421","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations","volume":"26","author":"Nevskaya","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0695","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/art.30361","article-title":"Induction of apoptosis in circulating angiogenic cells by microparticles","volume":"63","author":"Distler","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0700","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.22035","article-title":"Bone marrow endothelial progenitors are defective in systemic sclerosis","volume":"54","author":"Del Papa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2017.05.024_bb0705","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mvr.2015.01.004","article-title":"Decreased numbers of endothelial progenitor cells in patients in the early stages of systemic sclerosis","volume":"98","author":"Andrigueti","year":"2015","journal-title":"Microvasc Res"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0710","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/ard.2007.082131","article-title":"Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl. 62","key":"10.1016\/j.autrev.2017.05.024_bb0715","first-page":"S19","article-title":"Low circulating level of CD133+KDR+cells in patients with systemic sclerosis","volume":"28","author":"Mok","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0720","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1186\/ar3180","article-title":"Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"21","key":"10.1016\/j.autrev.2017.05.024_bb0725","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/CIRCULATIONAHA.108.787200","article-title":"Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells","volume":"118","author":"Zhu","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0730","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3899\/jrheum.080343","article-title":"Increased serum pentraxin 3 in patients with systemic sclerosis","volume":"36","author":"Iwata","year":"2009","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0735","first-page":"60","article-title":"Levels of circulating endothelial progenitor cells in systemic sclerosis","volume":"25","author":"Allanore","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0740","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1186\/ar4349","article-title":"Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis","volume":"15","author":"Manetti","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"23","key":"10.1016\/j.autrev.2017.05.024_bb0745","doi-asserted-by":"crossref","first-page":"14044","DOI":"10.1016\/S0021-9258(18)77454-1","article-title":"Heterogeneity of cell surface endothelin receptors","volume":"265","author":"Martin","year":"1990","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb0750","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1073\/pnas.88.8.3185","article-title":"Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor","volume":"88","author":"Lin","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0755","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-5793(91)80454-B","article-title":"Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation","volume":"282","author":"Takayanagi","year":"1991","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0760","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type a and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0765","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/art.1780340220","article-title":"Elevated plasma levels of endothelin-1 in systemic sclerosis","volume":"34","author":"Yamane","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0770","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb.11.4.7917311","article-title":"Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro","volume":"11","author":"Cambrey","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0775","first-page":"1566","article-title":"Significance of plasma endothelin-1 levels in patients with systemic sclerosis","volume":"19","author":"Yamane","year":"1992","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0780","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF00373425","article-title":"Elevated plasma endothelin levels in systemic sclerosis","volume":"287","author":"Kadono","year":"1995","journal-title":"Arch Dermatol Res"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0785","first-page":"1268","article-title":"Localization of endothelin-1 and its binding sites in scleroderma skin","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0790","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-4362.1997.00171.x","article-title":"Cutaneous localization of endothelin-1 in patients with systemic sclerosis: immunoelectron microscopic study","volume":"36","author":"Tabata","year":"1997","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0795","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10067-011-1688-3","article-title":"Urotensin-II in systemic sclerosis: a new peptide in pathogenesis","volume":"30","author":"Pehlivan","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0800","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/ard.2006.064493","article-title":"Reduced circulating levels of angiotensin-(1\u20137) in systemic sclerosis: a new pathway in the dysregulation of endothelial-dependent vascular tone control","volume":"66","author":"Pignone","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0805","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/jid.2015.323","article-title":"Activation of the thromboxane A2 receptor by 8-Isoprostane inhibits the pro-angiogenic effect of vascular endothelial growth factor in scleroderma","volume":"135","author":"Tsou","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0810","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/kel012","article-title":"Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis","volume":"45","author":"Ogawa","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0815","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780390711","article-title":"Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma","volume":"39","author":"Stein","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0820","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/rheumatology\/kei151","article-title":"Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features","volume":"45","author":"Volpe","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5 Pt 1","key":"10.1016\/j.autrev.2017.05.024_bb0825","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","article-title":"8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases","volume":"158","author":"Montuschi","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0830","first-page":"314","article-title":"Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0835","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2249.2003.02320.x","article-title":"Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features","volume":"134","author":"Takagi","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0840","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/rheumatology\/kei276","article-title":"Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine","volume":"45","author":"Dooley","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0845","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/niox.2000.0309","article-title":"Increased nitric oxide production in patients with systemic sclerosis","volume":"4","author":"Sud","year":"2000","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0850","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1378\/chest.115.5.1352","article-title":"Exhaled nitric oxide is increased in active fibrosing alveolitis","volume":"115","author":"Paredi","year":"1999","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0855","first-page":"547","article-title":"Increased nitric oxide in exhaled air in patients with systemic sclerosis","volume":"16","author":"Fajac","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0860","first-page":"1693","article-title":"Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension","volume":"27","author":"Rolla","year":"2000","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0865","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1378\/chest.119.5.1449","article-title":"Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease","volume":"119","author":"Moodley","year":"2001","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb0870","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/40.10.1089","article-title":"Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte\/macrophage cells","volume":"40","author":"Allanore","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb0875","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/thx.52.12.1051","article-title":"Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension","volume":"52","author":"Kharitonov","year":"1997","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0880","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4","article-title":"Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin","volume":"189","author":"Cotton","year":"1999","journal-title":"J Pathol"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0885","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2006.067504","article-title":"Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis","volume":"66","author":"Servettaz","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0890","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0895","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/0008-5472.948.65.3","article-title":"Controlling tumor growth by modulating endogenous production of reactive oxygen species","volume":"65","author":"Laurent","year":"2005","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.autrev.2017.05.024_bb0900","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.biopha.2005.03.009","article-title":"Differential modulation of normal and tumor cell proliferation by reactive oxygen species","volume":"59","author":"Nicco","year":"2005","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0905","first-page":"514","article-title":"The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma)","volume":"12","author":"Lee","year":"1985","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb0910","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.39817","article-title":"Platelets induce thymic stromal lymphopoietin production by endothelial cells: contribution to fibrosis in human systemic sclerosis","volume":"68","author":"Truchetet","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0915","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/art.39443","article-title":"Resolution of skin fibrosis by neutralization of the antifibrinolytic function of plasminogen activator inhibitor 1","volume":"68","author":"Lemaire","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb0920","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0925","first-page":"830","article-title":"Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage","volume":"70","author":"Venneker","year":"1994","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0930","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/art.22645","article-title":"Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells","volume":"56","author":"Xiang","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2017.05.024_bb0935","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.62.5.460","article-title":"Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis","volume":"62","author":"Selvi","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl. 91","key":"10.1016\/j.autrev.2017.05.024_bb0940","first-page":"S98","article-title":"Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis","volume":"33","author":"Corallo","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb0945","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/art.1780350111","article-title":"Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma","volume":"35","author":"Needleman","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0950","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12011","article-title":"Serum levels of interleukin-1\u03b1 in patients with systemic sclerosis","volume":"40","author":"Maekawa","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2017.05.024_bb0955","doi-asserted-by":"crossref","DOI":"10.1007\/s00393-016-0202-3","article-title":"Elevated serum levels of interleukin-1\u03b2 and interleukin-33 in patients with systemic sclerosis in Chinese population","author":"Zhang","year":"2016","journal-title":"Z Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0960","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.2009.119321","article-title":"The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis","volume":"69","author":"Manetti","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"10.1016\/j.autrev.2017.05.024_bb0965","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0970","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.1990.tb05340.x","article-title":"Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis","volume":"81","author":"Famularo","year":"1990","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb0975","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/art.1780330310","article-title":"Soluble interleukin-2 receptors in patients with systemic sclerosis. Clinical and laboratory correlations","volume":"33","author":"Degiannis","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb0980","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0985","first-page":"328","article-title":"Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis","volume":"24","author":"Hasegawa","year":"1997","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb0990","first-page":"308","article-title":"Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis","volume":"25","author":"Hasegawa","year":"1998","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2017.05.024_bb0995","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2017.05.024_bb1000","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-015-0308-1","article-title":"Association of elevated \u03b1-defensin levels with interstitial pneumonia in patients with systemic sclerosis","volume":"16","author":"Sakamoto","year":"2015","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10067-002-0684-z","article-title":"Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities","volume":"22","author":"Riccieri","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb1010","first-page":"2389","article-title":"Serum levels of interleukin 15 in patients with rheumatic diseases","volume":"28","author":"Suzuki","year":"2001","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9440(10)61712-9","article-title":"Expression of interleukin-15 in mouse and human atherosclerotic lesions","volume":"159","author":"Wuttge","year":"2001","journal-title":"Am J Pathol"},{"issue":"12","key":"10.1016\/j.autrev.2017.05.024_bb1020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.autrev.2017.05.024_bb1025","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","article-title":"Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement","volume":"70","author":"Manetti","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb1030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","article-title":"Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis","volume":"72","author":"Terras","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2017.05.024_bb1035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"15","key":"10.1016\/j.autrev.2017.05.024_bb1040","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.biomaterials.2014.02.012","article-title":"The role of macrophage phenotype in vascularization of tissue engineering scaffolds","volume":"35","author":"Spiller","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.autrev.2017.05.024_bb1045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcp.2016.01.016","article-title":"Notch signaling mediates crosstalk between endothelial cells and macrophages via Dll4 and IL6 in cardiac microvascular inflammation","volume":"104","author":"Pabois","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.autrev.2017.05.024_bb1050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166433","article-title":"Alternatively activated (M2) macrophage phenotype is inducible by endothelin-1 in cultured human macrophages","volume":"11","author":"Soldano","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb1055","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/exd.12727","article-title":"Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma","volume":"24","author":"Manetti","year":"2015","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4049\/jimmunol.150.2.556","article-title":"Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4","volume":"150","author":"Coleman","year":"1993","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb1065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.30190","article-title":"Mast cells are a source of transforming growth factor \u03b2 in systemic sclerosis","volume":"63","author":"H\u00fcgle","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000017979","article-title":"Expression of stem cell factor in the lesional skin of systemic sclerosis","volume":"197","author":"Yamamoto","year":"1998","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb1075","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1634\/stemcells.2007-1122","article-title":"In search of the in vivo identity of mesenchymal stem cells","volume":"26","author":"da Silva","year":"2008","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb1080","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","article-title":"Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine","volume":"16","author":"Cipriani","year":"2013","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb1085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/1523-1747.ep12286455","article-title":"Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF","volume":"108","author":"Denton","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/bbrc.2002.6449","article-title":"Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells","volume":"291","author":"Raymond","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.autrev.2017.05.024_bb1095","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.4049\/jimmunol.174.9.5740","article-title":"Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis","volume":"174","author":"Laplante","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb1100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.37705","article-title":"Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor \u03b2-dependent mesenchymal-to-mesenchymal transition","volume":"65","author":"Serrat\u00ec","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1105","first-page":"156","article-title":"Circulating adipokines and organ involvement in patients with systemic sclerosis","volume":"40","author":"Olewicz-Gawlik","year":"2015","journal-title":"Acta Reumatol Port"},{"issue":"3","key":"10.1016\/j.autrev.2017.05.024_bb1110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1468-3083.2011.04413.x","article-title":"Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis","volume":"27","author":"Toyama","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.autrev.2017.05.024_bb1115","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.0409781102","article-title":"The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles","volume":"102","author":"Distler","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 6","key":"10.1016\/j.autrev.2017.05.024_bb1120","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1042\/BST0371207","article-title":"The anti-angiogenic isoforms of VEGF in health and disease","volume":"37","author":"Qiu","year":"2009","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.autrev.2017.05.024_bb1125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/ard.2008.091918","article-title":"EULAR scleroderma trials and research group statement and recommendations on endothelial precursor cells","volume":"68","author":"Distler","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2017.05.024_bb1130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.141.1.158","article-title":"IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury","volume":"141","author":"Aronson","year":"1988","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997217301489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T20:37:02Z","timestamp":1692823022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997217301489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":225,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1568997217301489"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.024","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}